← Journeys Incubator Programme HIGH Founder
Programme Research
Journeys Incubator Programme ·
Programme Site
MEDIUM confidence Researched 2026-08-04 20:42 · profile: startup
The Journeys Incubator Programme is a 4-month entrepreneurship programme by the University of Helsinki that supports early-stage ventures with training, mentoring, and access to a university network. It exists to help founders validate and launch their ideas, regardless of sector, by providing structured support and a collaborative space in Helsinki.
No explicit criteria are listed on the page. Based on typical incubator selection, likely criteria include: clarity and viability of the business idea, founder motivation and commitment, potential for growth and impact, fit with the programme's resources and network, and the ability to benefit from a 4-month intensive programme.
No past winners are listed on the page. The programme is open to all sectors, so past cohorts likely include a diverse mix of early-stage ventures from University of Helsinki students, researchers, and external founders, with a focus on innovation and entrepreneurship.
The ideal applicant is a motivated founder with a clear, early-stage idea that can be developed within 4 months. They should be open to mentorship, willing to work full-time on the venture, and able to leverage the University of Helsinki's network and resources. The programme is sector-agnostic, so the idea should be innovative and have potential for real-world impact.
For Eniola Olutogun, the strongest angle is to frame the venture as a computational biology platform with immediate applications in drug resistance prediction, leveraging her unique pharmacist-ML background. The programme's open nature and Helsinki location (a growing biotech hub) make it a good fit for networking and validation, even though it is not biotech-specific. Emphasize the proof-of-concept (AUROC 0.804) and the clear roadmap to clinical partnerships (Servier) to show readiness for a 4-month sprint.
The programme is not biotech-specific, so the venture may be less of a fit than a healthtech-focused incubator. The 4-month duration may be short for a deep-tech venture, and the programme's location in Helsinki may not offer the same biopharma network as Paris. Also, the venture is not yet incorporated, which could be a minor concern for some incubators.
2026-08-04 20:06 · medium confidence
2026-07-31 00:35 · medium confidence